From July 1, 2022 to July 27, 2022, the company has repurchased 175,000 shares, representing 0.46% for ¥46.28 million. With this, the company has completed the repurchase of 350,000 shares, representing 0.93% for ¥692.31 million under the buyback announced on May 11, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,824 JPY | +0.63% | +0.79% | +13.98% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.98% | 901M | |
+55.19% | 815B | |
+45.45% | 654B | |
-6.09% | 354B | |
+21.92% | 337B | |
+10.18% | 302B | |
+18.26% | 247B | |
+2.41% | 229B | |
+13.31% | 219B | |
+10.86% | 171B |
- Stock Market
- Equities
- 4521 Stock
- News Kaken Pharmaceutical Co., Ltd.
- Tranche Update on Kaken Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2022.